Company Filing History:
2 out of 4 
1 out of 14 
1 out of 1 Years Active: 1988-1998
Title: Kenn Axo Gerdes: Innovator in Biological Containment and Immunization
Introduction
Kenn Axo Gerdes is a notable inventor based in Virum, Denmark. He has made significant contributions to the field of immunization and biological containment, holding a total of 5 patents. His innovative approaches have the potential to impact both medical and industrial applications.
Latest Patents
Gerdes's latest patents include a method of immunization using biologically contained bacterial cells. This method involves immunizing a vertebrate animal, such as a human, with a bacterial host cell that harbors a recombinant replicon. This replicon provides a stochastically expressed cell killing function, ensuring that the cells are biologically contained. Additionally, the replicon comprises a gene encoding an antigen displayed on the outer surface of the host cell, eliciting an immune response from the immunized animal. The antigen includes one or more epitopes from a pathogenic agent. Another significant patent focuses on biological containment, where a replicon encodes a cell killing function that is expressed under specific conditions in different host cells. This principle can be utilized in the industrial production of biosynthetic products and in the preparation of live vaccines.
Career Highlights
Throughout his career, Kenn Axo Gerdes has worked with several companies, including Gx Biosystems A/S and Alfred Benzon A/S. His work in these organizations has allowed him to develop and refine his innovative ideas in the field of biotechnology.
Collaborations
Gerdes has collaborated with notable individuals in his field, including So Slashedren Molin and Poul Kirketerp Andersson. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kenn Axo Gerdes is a distinguished inventor whose work in biological containment and immunization showcases his innovative spirit. His contributions have the potential to significantly influence both medical and industrial practices.